image
Revelation Biosciences, Inc. REVB
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.61
2.19 %
$ 2.52 M
Market Cap
-0.03
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
18.92%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Revelation Biosciences, Inc.
image
REVB has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart REVB

image
$70.0m$70.0m$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart REVB

image
$0.0$0.0($2.0m)($2.0m)($4.0m)($4.0m)($6.0m)($6.0m)($8.0m)($8.0m)($10.0m)($10.0m)($12.0m)($12.0m)($14.0m)($14.0m)($16.0m)($16.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart REVB

image
$2.0b$2.0b$0.0$0.0($2.0b)($2.0b)($4.0b)($4.0b)($6.0b)($6.0b)($8.0b)($8.0b)($10.0b)($10.0b)($12.0b)($12.0b)($14.0b)($14.0b)($16.0b)($16.0b)20232023202420242025202520262026202720272028202820292029